{reportSlug=global-non-alcoholic-steatohepatitis-market, reportId=34672, mktKeyword=Non-alcoholic Steatohepatitis, cagr=0.00, publishDate=Jan 2024, priceOption2=6500, reportTitle=Non-alcoholic Steatohepatitis Comprehensive Study by Type (Ocaliva, Elafibranor, Selonsertib, Cenicriviroc, Others), Application (Hypertension, Heart Disease, High Blood Lipid, Diabetes, Obesity), End Use Verticals (Pharma & CRO Industry, Hospitals, Diagnostic Labs, Academic Research Institutes) Players and Region - Global Market Outlook to 2030, baseYr=2023, totalTableFig=200, priceOption1=3450, forecastYr=2030, noOfPages=239, reportKey=34406, breadcrum=Global Non-alcoholic Steatohepatitis}
We do not share your information with anyone. However, we may send you
emails based on your report interest from time to time. You may contact
us at any time to opt-out.
Select User Access Type
Key Highlights of Report
Jan 2024
239 Pages
66 Tables
Base Year: 2023Coverage: 15+ Companies; 18
Countries